Transparency Market Research in its new report titled, “Plasma Expanders Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2026,” provides key insights on the plasma expanders market. The TMR report anticipates that the increased government funding for public hospitals and risen complexity of surgeries will drive the plasma expanders market during the forecast period i.e, 2018-2026. In addition, technological advancements and rapidly improving private health care infrastructure are likely to boost the market in the near future. On the other hand, high costs associated with storage and transportation of plasma expanders are projected to restrain the global plasma expanders market to a certain extent in the next few years. Moreover, price sensitivity and stringent government regulations regarding approval of biologic products are likely to hamper the global market in the next few years, says the report.
There are different types of fluids used in the management of shock including whole blood plasma, plasma substitute or plasma expander, colloidal solution of dextran, colloidal solution of hydroxyethyl starch, and crystalline solution of sodium chloride and starch. Plasma expanders are agents that have high molecular weight and that boost the plasma volume by increasing the osmotic pressure. After administration, plasma expanders remain for an enough time to restore the volume of the circulatory fluid by increasing the osmotic pressure. There are two types of plasma expanders: colloidal and crystalloid. Crystalloid fluid is commonly used to expand the plasma volume. Crystalloid fluid is balanced salt solution that freely crosses the capillary walls and stays in the intravascular space for a shorter time compared to colloidal fluid. Also, the crystalloid fluids exhibit an early plasma expansion, which is of shorter life span.
The TMR report has segregated the global plasma expanders market based on type, application, distribution channel, and region. Based on type of plasma expander, the market is divide into dextran, hydroxyethyl starch, human albumin, PEGylated albumin, polyvinylpyrrolidone (PVP), and gelatin. In terms of application, the market is classified into burns & scalds, acute massive bleeding, vomiting & diarrhea, and others. On the basis of distribution channel, the global market is segmented into online pharmacies, retail pharmacies, and hospital pharmacies. From a regional standpoint, the global plasma expanders market is divided into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is expected to hold the largest share of the global market from 2018 to 2026, due to high per capita income of people in the region. Europe is expected to be the second-largest market for plasma expanders during the forecast period, due to high investments in research and development and increased funding for hospitals in the region. The Asia Pacific plasma expanders market is expected to expand at a rapid pace during the forecast period. Growth of the market in the region is attributable to rapidly developing health care infrastructure and growing adoption of technologies in the region.
Key players operating in the global plasma expanders market are Biogen idec Inc., Kedrion Biopharma Inc., CSL Behring, Shire US, Inc., Grifols USA, LLC, Pfizer Inc., Abbott, and Bayer AG.
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453